Phase II Study of ABT-122, a Tumor Necrosis Factor- and Interleukin-17A-Targeted Dual Variable Domain Immunoglobulin, in Patients With Psoriatic Arthritis With an Inadequate Response to Methotrexate
| Image |  |
|---|---|
| Description | scientific article published on 01 November 2018 |
| Author/s |
author: Ahmed A Othman Heikki Mansikka Mark C Genovese Paul M. Peloso Ahmed Mohamed Abdel Ghany Othman |
| Publication date | November 1, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |